Accelerate
Discovery.
Scale With
Confidence.
Bridge BioHealth connects Biotech and pharmaceutical research, MBA-led business strategy, and evidence-based wellness — reducing friction at every stage of your pipeline.
What's Your Situation?
Answer 3 quick questions and we'll route you to exactly the right tool or service — no browsing required.
What best describes your situation right now?
Pick the one that fits most — we'll route you to exactly the right tool.
Your Lab Is Sitting on
Untapped Revenue.
Every day without action is money left on the table. Here's exactly what Bridge BioHealth can unlock for you — with real numbers, real pricing, and real ROI.
Unpublished Data → Manuscript
50% of clinical data is never published. That's your IP sitting idle.
Grant Writing → Non-Dilutive Funding
Professional grant writing increases success rate from 15% to 28%.
Idle Lab Assets → Marketplace Revenue
40% of lab equipment sits unused. That's money you're not collecting.
M&A Due Diligence → Deal Protection
70% of biotech acquisitions destroy value. One check could save millions.
You Describe It.
AI Does the Work.
Every tool on this platform is AI-powered. You spend 10 minutes answering questions. Our AI spends the next few seconds doing what would take your team weeks.
Evaluates Your Drug Program
Go/No-Go Decision Engine
You answer 6 structured steps. AI scores 5 domains, flags hard-stops, generates a 90-day de-risking roadmap, and writes a full executive report.
Writes Your Manuscript
Data → Publication Program
You describe your dataset. AI analyzes publication viability, identifies the right journal, structures the paper, and drafts the full manuscript — introduction through discussion.
Writes Your Grant Proposal
NIH · NSF · DoD · ERC
You share your preliminary data and aims. AI customizes the proposal for your specific funder — Specific Aims, significance, innovation, approach — all formatted to agency requirements.
Runs Your M&A Due Diligence
Pre-Acquisition Intelligence
You answer the questionnaire. AI scores 5 dimensions, surfaces deal-killer flags, recommends deal structure, quantifies synergies, and generates a Goldman Sachs-level acquisition report.
Click any card to watch the AI work in real time
End-to-End Solutions
Built for Biotech.
Drug Design & Regulatory Strategy
Strategic guidance on pharmaceutical drug design, multi-omics data integration, CRO outsourcing negotiation, and navigating complex regulatory pathways from IND to NDA.
- Drug Screening & Design
- Multi-Omics Integration
- CRO Strategy & Referral
- Regulatory Pathways
MBA-Led Growth & Federal Contracting
Go-to-market strategies, operational scaling, securing federal contracts (SBIR/STTR), and implementing tech-forward infrastructure for investment-ready biotech startups.
- Go-to-Market Strategy
- Federal Contract Acquisition
- Operational Scaling
- Investor Readiness
Evidence-Based Wellness Programs
Empowering individuals and organizations with science-backed wellness strategies. Reducing friction in clinical validation pipelines and building sustainable health cultures.
- Organizational Wellness
- Clinical Validation Support
- Individual Coaching
- Wellness Infrastructure
How It Works
From first conversation to verified results — a clear, friction-free engagement process designed around your timeline and goals.
Book a Free Discovery Call
Schedule a focused 30-minute call with a senior Bridge BioHealth expert — matched to your challenge. Ph.D. scientist for drug programs, MBA strategist for business, NP/MPH for wellness. We listen first.
"You'll leave with clarity on your options and a clear recommendation — even if you don't move forward with us."
We Scope Your Engagement
Within 48–72 hours, we deliver a tailored proposal — scope, timeline, deliverables, and pricing. No templates, no guesswork. Every engagement is designed around your specific program and goals.
"We've scoped everything from single IND packages to multi-year integrated partnerships. You approve every detail before we start."
Expert Team Gets to Work
Your dedicated team — scientists, strategists, and coaches — begins execution. You get weekly progress updates, a shared workspace, and direct access to your lead consultant. No account managers in the way.
"We operate as an extension of your team, not a vendor. You'll know exactly what's happening and why at every step."
Deliver Results. Stay Connected.
We deliver against the agreed scope — IND filed, grant won, revenue grown, team performing. Then we send a full outcome summary and offer ongoing support options. Most clients stay with us long-term.
"95% client retention rate. Because results speak louder than proposals."
Monthly retainers cancel with 30 days notice. Project work has zero ongoing commitment.
Most engagements kick off within 5–10 business days of signing. Urgent timelines accommodated.
If a deliverable doesn't meet scope, we revise at no cost. We stand behind our work.
If You Don't Use It,
You're Losing It.
Unpublished data. Idle equipment. Stalled pipelines. Preliminary results gathering dust. Every day you wait, someone else is monetizing what you already have. Share it with us. We'll make it work for you.
You Already Have
What You Need.
You Just Need Us
To Unlock It.
The biotech industry wastes billions every year on duplicated research, idle assets, and missed funding opportunities — not because the science isn't there, but because the infrastructure to share it doesn't exist.
Bridge BioHealth is that infrastructure. We take what you already have — data, assets, preliminary results, pipeline programs — and turn them into publications, revenue, grants, and strategic partnerships.
Where Science Meets
Strategic Intelligence.
Most consulting firms pick a lane — science or business. We bridge both. Our team combines deep pharmaceutical expertise with MBA-level strategic thinking and a genuine commitment to human wellness.
Reduce Drug Development Friction
We streamline the path from discovery to clinical validation — cutting timelines, reducing redundant spend, and connecting you with the right CRO partners.
Investment-Ready Operations
Scalable, secure, and commercially viable business infrastructure. We prepare biotech startups for federal contracts, VC rounds, and strategic partnerships.
Unlock Hidden Asset Value
Your idle compound libraries, genomic datasets, and equipment time have real market value. Our marketplace turns lab overhead into revenue or IP credit.
Whole-Organization Wellness
Evidence-based health coaching for teams and individuals — because peak scientific performance starts with human health and organizational resilience.
Your Unused Resources
Are Someone's Breakthrough.
A next-generation platform where scientists, labs, and companies share compound libraries, genomic data, peptides, screening time, and equipment — across academia and industry. Non-custodial. Transparent. Efficient.
Trade, share, or license lab resources — across academia and industry.
Ready to list your resources?
Earn revenue, IP credit, or collaboration opportunities from your lab's idle assets. Free to list, always.
The Go-To Platform for
Unbiased Drug Program Decisions
Evidence-based Go/No-Go evaluations for wet lab programs, AI-generated leads, theoretical proposals, and clinical-stage assets. Grounded in 8 peer-reviewed publications and FDA guidance.
From $49
Go / No-Go Decision Engine
Submit any biotech, pharma, or science program for a structured, 6-domain, evidence-based assessment. Anonymized. No bias. Grounded in published drug attrition data.
Free preview
AI Lead Evaluation
A streamlined 3-step assessment purpose-built for AI-generated molecules, virtual screening hits, and computationally-derived leads. Evaluate the evidence, not the algorithm.
8
Peer-reviewed citations
5
Evidence domains scored
48h
Expert peer review SLA
90-day
De-risking roadmap
Methodology & Validation
Every weight, threshold, and hard-stop flag is grounded in peer-reviewed drug attrition research. Read the full methodology, citations, and known limitations — full scientific transparency.
How Much Are You
Leaving on the Table?
Pick your situation and see an instant estimate of the value Bridge BioHealth can unlock for you — manuscripts, grants, marketplace revenue, or M&A protection.
Full ROI Calculator with all scenarios →How many unpublished datasets do you have?
Select an option above to see your estimate
Illustrative estimates based on industry averages. Not a guarantee of outcome.
What the Data
Actually Says.
The global CRO market will reach $96B by 2028, driven by biotech outsourcing.
Grand View Research 2024
Real Results From
Real Collaborators.
"Bridge BioHealth transformed our CRO selection process. Their strategic guidance saved us 6 months and over $400K in outsourcing costs. Truly exceptional consulting."
"The BioShare Marketplace is a game-changer for academic labs. We monetized our compound library and found three new collaboration partners within weeks of listing."
"Their MBA-led business consulting helped us win our first SBIR Phase II contract. The federal contracting expertise is unmatched in the biotech consulting space."
"We shared our HTS platform time through the marketplace and generated $80K in revenue from idle capacity. Bridge BioHealth's platform is exactly what the industry needed."
"The health coaching program for our team was evidence-based and genuinely impactful. Productivity increased measurably. I recommend Bridge BioHealth to every biotech founder."
"From regulatory strategy to investor readiness, Bridge BioHealth covered every angle. We closed our Series A six months ahead of schedule thanks to their operational guidance."
Ready to Bridge
the Gap?
Whether you need biotech consulting, business strategy, health coaching, or want to join the BioShare Marketplace — let's start the conversation.
List your lab resources, browse available compounds, or request a collaboration.
Go to BioShare Marketplace